Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.2B bought by 555 insiders at 344 companies
- $9.7B sold by 672 insiders outside a trading plan
- $4.8B sold by 994 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$161M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$7.2M 73,000 shares at $98.50 9.3% of stakeTraded Sep 8–9 Filed Sep 9
-
Brendan Martin Mulshine Co-President and CRORYANRyan Specialty Holdings, Inc.Sale$1.6M 40,000 shares at $40.51 35% of stakeTraded Sep 8 Filed Sep 9
-
William T Yoon Chief Legal OfficerDBXDropbox, Inc.Planned sale$431K 12,382 shares at $34.78 3.3% of stakeTraded Sep 4 Filed Sep 9
-
Daniel S Peyovich CEODYDycom Industries, Inc.Buy$252K 850 shares at $296.76 +1.4% to stakeTraded Sep 9 Filed Sep 9
-
Kumar Budur Chief Medical OfficerHRMYHarmony Biosciences Holdings, Inc.Planned sale$1.5M 33,954 shares at $42.80 72% of stakeTraded Sep 4–8 Filed Sep 9
-
Sean Chihhsiang Chen COOAMBQAmbiq Micro, Inc.Planned sale$858K 15,000 shares at $57.17 11% of stakeTraded Sep 4 Filed Sep 9
-
Deborah Pfeiffer EVP & Pres, Presort ServicesPBIPitney Bowes Inc.Planned sale$342K 20,000 shares at $17.11 20% of stakeTraded Sep 8 Filed Sep 9
-
Mads Bodenhoff SVP & PaoASNDAscendis Pharma A/SSale$811K 3,000 shares at $270.19 100% of stakeTraded Sep 8 Filed Sep 9
-
Nathaniel Glenn Crook Chief Commercial OfficerAMPLAmplitude, Inc.Planned sale$3.9M 300,000 shares at $12.99 16% of stakeTraded Sep 4 Filed Sep 9
-
Axel Schwan Pres., Tim Hortons US & CanadaQSRRestaurant Brands International Inc.Sale$4.7M 57,574 shares at $81.14 22% of stakeTraded Sep 4 Filed Sep 9
-
Nikhil Chandhok Chief Product & Tech. OfficerCRCLCircle Internet Group, Inc.Planned sale$2.7M 26,666 shares at $100.40 3.6% of stakeTraded Sep 8 Filed Sep 9
-
Casey M. Nault EVP, GC & SecretaryCDECoeur Mining, Inc.Planned sale$211K 10,000 shares at $21.06 1.9% of stakeTraded Sep 8 Filed Sep 9
-
Amine Asmerom Chief Accounting OfficerCHYMChime Financial, Inc.Planned sale$643K 19,505 shares at $32.94 6.5% of stakeTraded Sep 8 Filed Sep 9
-
Keith D Larson General Counsel and SecretaryVGVenture Global, Inc.Planned sale$35.7M 2,350,000 shares at $15.18 100% of stakeTraded Sep 8–9 Filed Sep 9
-
Dominic Phillips See RemarksIOTSamsara Inc.Planned sale$1.3M 29,619 shares at $44.25Traded Sep 4 Filed Sep 9
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$939K 3,300 shares at $284.40 0.8% of stakeTraded Sep 8 Filed Sep 9
-
Thomas C Indelicarto EVP, Gen Counsel & SecretaryVRSNVerisign Inc.Planned sale$145K 500 shares at $289.16 1.5% of stakeTraded Sep 8 Filed Sep 9
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $499.03 2.8% of stakeTraded Sep 8 Filed Sep 9
-
Adam R Kalbermatten Chief Commercial OfficerKRMDKORU Medical Systems, Inc.Buy$101K 32,000 shares at $3.16 +8.8% to stakeTraded Sep 8 Filed Sep 9
-
Scott D. Lipesky COOANFAbercrombie & Fitch CompanySale$294K 2,000 shares at $146.82 1.4% of stakeTraded Sep 4 Filed Sep 9
-
Mark W. Webb CFOJILLJ. Jill, Inc.Planned sale$102K 5,086 shares at $20.15 3.1% of stakeTraded Sep 4 Filed Sep 9
-
Donald A Bergstrom President, R&DRLAYRelay Therapeutics, Inc.Planned sale$162K 8,530 shares at $18.97 2.1% of stakeTraded Sep 8 Filed Sep 9
-
Thomas F. Shannon CEOLUCKLucky Strike Entertainment CorporationBuy$176K 30,000 shares at $5.86 +1% to stakeTraded Sep 9 Filed Sep 9
-
Tiffany N. Meriweather Chief Admin. & Legal OfficerFIVNFive9, Inc.Planned sale$161K 5,114 shares at $31.55 2% of stakeTraded Sep 8 Filed Sep 9
-
Thomas Catinazzo CFORLAYRelay Therapeutics, Inc.Planned sale$336K 17,717 shares at $18.94 13% of stakeTraded Sep 8 Filed Sep 9
-
Milton C Ault III ChairGPUSHyperscale Data, Inc.Buy$407K 2,148,691 shares at $0.1900Traded Sep 3–4 Filed Sep 9
-
Yoav Landman Chief Technology OfficerFROGJFrog Ltd.Planned sale$4M 45,000 shares at $89.27 0.9% of stakeTraded Sep 4 Filed Sep 9
-
Chad F Phipps See remarks below.ZBHZimmer Biomet Holdings Inc.Sale$295K 3,000 shares at $98.35 4.4% of stakeTraded Sep 4 Filed Sep 9
-
Sanjiv Patel CEORLAYRelay Therapeutics, Inc.Planned sale$913K 48,199 shares at $18.94 8.5% of stakeTraded Sep 8 Filed Sep 9
-
John F Barry CEOPSECProspect Capital CorporationBuy$2.7M 1,217,105 shares at $2.24 +1.4% to stakeTraded Sep 4 Filed Sep 9
-
Nichlas A Fink SVP, Chief Accounting OfficerCSCOCisco Systems, Inc.Planned sale$249K 2,274 shares at $109.36 6.8% of stakeTraded Sep 8 Filed Sep 9
-
Abraham Ceesay CEORAPPRapport Therapeutics, Inc.Planned sale$374K 8,210 shares at $45.61 1.8% of stakeTraded Sep 8 Filed Sep 9
-
Xu Chen Chief Marketing OfficerBZKanzhun LimitedSale$3.4M 400,000 shares at $8.50 72% of stakeTraded Sep 4 Filed Sep 9
-
Fred Aslan CEOARTVArtiva Biotherapeutics, Inc.Planned sale$256K 23,429 shares at $10.92 1.6% of stakeTraded Sep 8 Filed Sep 9
-
Hong Q Hou CEOSMTCSemtech CorporationPlanned sale$277K 2,000 shares at $138.71 3.2% of stakeTraded Sep 4 Filed Sep 9
-
Siphelele Jiyane Chief Accounting OfficerAFRMAffirm Holdings, Inc.Sale$1.8M 25,000 shares at $72.41 10% of stakeTraded Sep 4 Filed Sep 9
-
Brian Aquilino COOGOLDGold.com, Inc.Sale$313K 6,667 shares at $47.02 100% of stakeTraded Sep 8 Filed Sep 9
-
Judith L Bacchus Vice PresidentKMTKennametal Inc.Sale$293K 9,676 shares at $30.29 38% of stakeTraded Sep 8 Filed Sep 9
-
Kate Dixon Controller, CAOAEPAmerican Electric Power Company, Inc.Planned sale$250K 2,000 shares at $125.00 11% of stakeTraded Sep 8 Filed Sep 9
-
Laura Allison Dukes CFOIVZInvesco PlcSale$1M 31,075 shares at $33.16 11% of stakeTraded Sep 4 Filed Sep 9
-
Carol Meltzer EVP, Gen. Counsel & SecretaryGOLDGold.com, Inc.Sale$187K 4,000 shares at $46.86 73% of stakeTraded Sep 8 Filed Sep 9
-
Saar Dotan EVP Countries & BDZIMZIM Integrated Shipping Services Ltd.Sale$112K 3,690 shares at $30.32 3.9% of stakeTraded Sep 8 Filed Sep 9
-
Peng Lu PresidentPHVSPharvaris N.V.Planned sale$610K 15,000 shares at $40.68 19% of stakeTraded Sep 8 Filed Sep 9
-
Paul Glavine Chief Growth OfficerHELPCybin Inc.Buy$1M 90,000 shares at $11.59 +2.3% to stakeTraded Aug 31 Filed Sep 9
-
Robert E Hull COOHRHealthcare Realty Trust IncorporatedSale$401K 21,000 shares at $19.11 7.1% of stakeTraded Sep 8 Filed Sep 9
-
Ingrid A Estrada SVPKEYSKeysight Technologies Inc.Sale$652K 2,000 shares at $326.10 1.9% of stakeTraded Sep 4 Filed Sep 9
-
Gang Ye COOSESea LimitedPlanned sale$4.5M 40,000 shares at $113.01 5% of stakeTraded Sep 4–8 Filed Sep 9
-
Yanjun Wang CCO and GCSESea LimitedPlanned sale$339K 3,000 shares at $113.02 24% of stakeTraded Sep 4–8 Filed Sep 9
-
Steven Ratner EVP, CHROMRCYMercury Systems IncSale$338K 4,000 shares at $84.51 17% of stakeTraded Sep 3 Filed Sep 8
-
Anthony Michael Denier PresidentBULLWebull CorporationPlanned sale$516K 53,846 shares at $9.58 2.3% of stakeTraded Sep 8 Filed Sep 8
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.